FDA ISSUES STIFFER WARNINGS FOR ED

DECEMBER 01, 2007

New labeling on the the erectile dysfunction drugs Cialis (tadalafil tablets), Levitra (vardenafil HCl), and Viagra (sildenafil citrate) will warn men of possible hearing loss resulting from these products.

The new FDA warnings were developed after what agency officials described as a ?very small number? of patients who experienced sudden loss of hearing after taking the drugs.

FDA said it plans to require the same label warnings for Revatio (sildenafil citrate), for pulmonary arterial hypertension. The FDA is currently working with the sponsor to revise the label for Revatio.



SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.